BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11188854)

  • 1. [Collagenase production increases in rheumatoid arthritis and osteoarthritis synoviocytes incubated].
    Montrull HL; Brizuela NY; Demurtas SL; Strusberg AM; Spitale LS; Meirovich CI
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(1):51-7. PubMed ID: 11188854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
    Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
    BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis.
    Clark IM; Powell LK; Ramsey S; Hazleman BL; Cawston TE
    Arthritis Rheum; 1993 Mar; 36(3):372-9. PubMed ID: 8452582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.
    Tchetverikov I; Ronday HK; Van El B; Kiers GH; Verzijl N; TeKoppele JM; Huizinga TW; DeGroot J; Hanemaaijer R
    Ann Rheum Dis; 2004 Jul; 63(7):881-3. PubMed ID: 15194590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes.
    Alquraini A; Jamal M; Zhang L; Schmidt T; Jay GD; Elsaid KA
    Arthritis Res Ther; 2017 May; 19(1):89. PubMed ID: 28482921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10.
    Tolboom TC; Pieterman E; van der Laan WH; Toes RE; Huidekoper AL; Nelissen RG; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2002 Nov; 61(11):975-80. PubMed ID: 12379519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators.
    Choi HM; Lee YA; Lee SH; Hong SJ; Hahm DH; Choi SY; Yang HI; Yoo MC; Kim KS
    Arthritis Res Ther; 2009; 11(6):R161. PubMed ID: 19883500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
    Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
    Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F; Siddiqui AA
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
    Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
    Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dynamics of matrix metalloproteinase (MMP)-13 in the patients with rheumatoid arthritis].
    Itoh T; Uzuki M; Shimamura T; Sawai T
    Ryumachi; 2002 Feb; 42(1):60-9. PubMed ID: 11925908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
    Nakano S; Ikata T; Kinoshita I; Kanematsu J; Yasuoka S
    Clin Exp Rheumatol; 1999; 17(2):161-70. PubMed ID: 10342041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.